Mutual Funds Commodities Research Tax Planning IPO Our Team Contact Us  
Google
Web www.equitybulls.com
Stock Report

| More

Laurus Labs Ltd crosses revenue of Rs. 700 crores in Q2 FY20

Posted On: 2019-10-31 19:35:42


Laurus Labs Ltd. (Laurus BSE: 540222, NSE: LAURUSLABS, ISIN: INE947Q01010), a leading research and development driven pharmaceutical company in India announcesits Q2 & H1 FY20 results.

Q2 FY20 Laurus reported:

- Consolidated Revenue at INR. 7,124 mn, up 21% (Y-o-Y) and 29% (Q-o-Q)
- EBITDA INR 1,391 mn, up 61% (Y-o-Y) and 60% (Q-o-Q)
- EBITDA margins at 20 %
- PAT at INR. 566 mn, up 249% (Y-o-Y) and 275% (Q-o-Q)
- EPS (Diluted) for the period at INR. 5.3 per share (not annualised), up 253% (Y-o-Y) and 279% (Q-o-Q)

H1 FY20 Laurus reported:

- Consolidated Revenue at INR. 12,630 mn, up 12% (Y-o-Y)
- EBITDA INR 2,261 mn, up 34% (Y-o-Y)
- EBITDA margins at 18 %
- PAT at INR. 716 mn, up 118% % (Y-o-Y)
- EPS (Diluted) for the period at INR. 6.7 per share (not annualised), up 116% (Y-o-Y)

Commenting on the results announcement, Dr. Satyanarayana Chava - CEO said, "The quarter's performance demonstrates our ability to execute our long term strategy, with enhanced revenue contribution from Formulations business contributing positively to both top line and margins. The LMIC tender business remains a major part of the FDF strategy along with developed markets of North America and Europe.

We have recorded robust growth across most of our divisions. Other API division showed a strong growth during the quarter on the back of increase in new product additions; with Oncology and Synthesis maintaining their growth momentum. With the impending shift in the treatment regimen in South Africa, we are witnessing a slowdown in sales in ARV API business for FY20.

On the regulatory side, we have received EIRs for our Units 1 & 3. Unit 4 successfully completed its maiden USFDA audit with Zero observations also received EIR. We remain committed to highest level of Compliance & Quality. With our EBITDA Margins at 20% I am very confident that our performance is back on high growth track."

Commenting on the results announcement, V V Ravi Kumar, ED & Chief Financial Officer said, "Our Total Revenues from Operations came in at INR 7,124 mn. With the improved revenue and better product mix our Gross Margins continue to improve. Our EBITDA margins also showed a significant improvement at 20% for Q2 FY20. The growth in EBITDA was led by higher Operating Leverage and also with softer key Raw Material prices from China. We are encouraged by the robust growth seen in FDF and Other API business resulting in higher utilization of our new Units - 2 & 4. With the focus solely being on growth and improvement in Operating Leverage, we remain confident of improving our return ratios and also achieving FCF positive status from FY21."

Shares of Laurus Labs Ltd was last trading in BSE at Rs.370.6 as compared to the previous close of Rs. 364.05. The total number of shares traded during the day was 2200 in over 203 trades.

The stock hit an intraday high of Rs. 374 and intraday low of 364.85. The net turnover during the day was Rs. 809079.


Source: Equity Bulls

Click here to send ur comments or to feedback@equitybulls.com





Other Headlines:

CESC Ltd arm increases stake in Noida Power Company Ltd to 72.73%

Indus Towers Ltd board to consider Q3FY21, 9MFY21 results on Jan 28, 2021

Metropolis Healthcare to acquire Hitech Diagnostic Centre to strengthen its leadership position in South India

Oberoi Realty Limited board to announce Q3 results on Jan 22, 2021

PG Electroplast Ltd board to consider Q3FY21 results on Jan 25, 2021

TGV Sraac Ltd board to approve 3rd quarter results on Jan 25, 2021

Natural Capsules Ltd board to announce third quarter results on Jan 25, 2021

India Grid Trust board to consider distribution, financial information on Jan 22, 2021

High Energy Batteries India Ltd board to approve quarterly results on Feb 6, 2021

Security and Intelligence Services (India) Ltd board to consider Q3FY21, 9MFY21 results on Feb 3, 2021

Stylam Industries Limited board to announce third quarter results on Jan 25, 2021

Phillips Carbon Black Ltd board to approve interim dividend on Jan 20, 2021

Shriram City Union Finance Ltd board to consider 3rd quarter results on Jan 29, 2021

Shreyans Industries Ltd board to approve quarterly results on Feb 11, 2021

Firstsource Solutions Ltd board to announce Q3FY21 results on Feb 9, 2021

3i Infotech Ltd board to consider Q3 results on Jan 28, 2021

HDFC Bank's Net NPA at 0.09%

HDB Financial Services Limited reports loss of Rs. 44.3 crore in Q3FY21

HDFC Bank increases distribution network YoY

HDFC Bank's balance sheet size grows 18.6% YoY

HDFC Securities Limited posts PAT of Rs. 166.6 crore in Q3FY21

HDFC Bank's Capital Adequacy Ratio was at 18.9% as of Dec 31, 2020

Parmax Pharma Limited approves preferential issue

Rossari Biotech Ltd board to approve quarterly results on Jan 23, 2021

Aditya Vision Limited opens 57th showroom

JBM Auto Limited receives orders for supply of 700 JBM CITYLIFE buses

Gujarat Hotels Ltd posts net profit of Rs. 0.58 crore in Q3FY21

Sacheta Metals Ltd Q3FY21 net profit at Rs. 0.89 crore

HDFC Bank Ltd Q3FY21 consolidated PAT climbs to Rs. 8769.33 crores

Star Cement Limited commences commercial production of new grinding unit

Chembond Chemicals Ltd Q3FY21 consolidated PAT zooms to Rs. 8.44 crore

Apollo Pipes Ltd reports net profit of Rs. 16.33 crores in Q3 FY2020-21

Apollo Hospitals begins vaccinating healthcare workers

International Travel House Ltd Q3FY21 loss at Rs. 10.69 crore

GE T&D India Limited to sell its GLobal Engineering Operations Division

IRB InvIT Fund to distribute Rs. 2.50 per unit for Q3 FY21

Smruthi Organics Ltd board recommends 2:1 bonus shares

Smruthi Organics Ltd Q3FY21 net profit drops QoQ to Rs. 5.10 crore

SpiceJet to connect Delhi with Sikkim with a daily non-stop flight

Indian Railway Finance Corporation Ltd raised Rs 1398.63 crores from 31 anchor investors ahead of its public issue

CRISIL A1+ rating reaffirmed to PNB Gilts Ltd's Rs. 1000 commercial paper programme

Pudumjee Paper Products Ltd board to announce Q3 results on Jan 23, 2021

SML ISUZU Ltd board to consider Q3FY21 results on Feb 5, 2021

Indian Energy Exchange Ltd board to consider interim dividend on Jan 21, 2021

LIC Housing Finance Ltd board to announce 3rd quarter results on Jan 29, 2021

CARE Ratings Ltd board to consider dividend, Q3 results on Feb 6, 2021

The Dharamsi Morarji Chemical Company Limited board to approve third quarter results on Feb 8, 2021

IDBI Bank Ltd board to announce 3rd quarter results on Jan 28, 2021

Reliance Industries Ltd board to consider Q3FY21, 9MFY21 results on Jan 22, 2021

Tata Consumer Products Ltd board to announce Q3FY21 results on Feb 2, 2021



Website Created & Maintained by : Chennai Scripts
West Mambalam, Chennai - 600 033,
Tamil Nadu, India

disclaimer copyright © 2005 - 2020